NEUPOGEN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Neupogen Market, By Indication (Chemotherapy-induced neutropenia in non-myeloid malignancies, Neutropenia in acute myeloid leukemia (AmL) patients post induction or consolidation chemotherapy, Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT), Mobilization of autologous hematopoietic progenitor cells for leukapheresis, Chronic neutropenia (congenital, cyclic, idiopathic), and Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)), By Dose Strength (300mcg/1mL, 480mcg/1.6mL, 300MGC/0.5mL, and 480mcg/0.8mL), By Packaging (Single-use vials and Prefilled syringes), By Patient Age Group (Pediatric, Adult, and Geriatric), By Sales Channel (Online and Offline), By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, and Others (Academic & Research Institutions, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 11 Mar, 2026
Code: CMI8115
Page number: 165
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Neupogen Market, By Indication
  - Global Neupogen Market, By Dose Strength
  - Global Neupogen Market, By Packaging
  - Global Neupogen Market, By Patient Age Group
  - Global Neupogen Market, By Sales Channel
  - Global Neupogen Market, By End User
  - Global Neupogen Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- Reimbursement Scenario
- Epidemiology
- Pricing Analysis
Global Neupogen Market, By Indication, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Chemotherapy-induced neutropenia in non-myeloid malignancies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Neutropenia in acute myeloid leukemia (AML) patients post-induction or consolidation chemotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Mobilization of autologous hematopoietic progenitor cells for leukapheresis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Chronic neutropenia (congenital, cyclic, idiopathic)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By Dose Strength, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- 300mcg/1mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- 480mcg/1.6mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- 300MGC/0.5mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- 480mcg/0.8mL
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By Packaging, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Single-use vials
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Prefilled syringes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By Patient Age Group, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Geriatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By Sales Channel, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Online
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Offline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Oncology Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Surgical Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Academic & Research Institutions, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Neupogen Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dose Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Packaging, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Neupogen Market' - Global forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now